Home » Stocks » Acutus Medical

Acutus Medical, Inc. (AFIB)

Stock Price: $30.64 USD -3.04 (-9.03%)
Updated Sep 21, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 840.48M
Revenue (ttm) 3.63M
Net Income (ttm) -100.44M
Shares Out 27.43M
EPS (ttm) -4.08
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Sep 21, 2020
Last Price $30.64
Previous Close $33.68
Change ($) -3.04
Change (%) -9.03%
Day's Open 32.81
Day's Range 30.41 - 32.81
Day's Volume 170,296
52-Week Range 24.00 - 38.99

More Stats

Market Cap 840.48M
Enterprise Value 852.03M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 27.43M
Float 20.78M
EPS (basic) n/a
EPS (diluted) -4.08
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 149,266
Short Ratio 0.43
Short % of Float 1.00%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 231.41
PB Ratio n/a
Revenue 3.63M
Operating Income n/a
Net Income -100.44M
Free Cash Flow n/a
Net Cash -11.55M
Net Cash / Share -0.42
Gross Margin -176.40%
Operating Margin n/a
Profit Margin -2,765.47%
FCF Margin n/a
ROA n/a
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (5)

Buy 4
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$36.75*
(19.94% upside)
Low
30.0
Current: $30.64
High
40.0
Target: 36.75
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018
Revenue2.842.17
Revenue Growth30.93%-
Gross Profit-6.41-5.34
Operating Income-72.07-37.75
Net Income-97.04-47.91
Shares Outstanding0.670.55
Earnings Per Share-144.41-87.78
Operating Cash Flow-55.99-33.78
Capital Expenditures-3.40-2.04
Free Cash Flow-59.38-35.82
Cash & Equivalents71.9517.90
Total Debt41.1325.87
Net Cash / Debt30.82-7.97
Assets10525.95
Liabilities77.9139.45
Book Value-226-132
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Acutus Medical, Inc.
Country United States
Employees 224
CEO Vince J. Burgess

Stock Information

Ticker Symbol AFIB
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: AFIB
IPO Date August 6, 2020

Description

Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. It offers AcQMap console and workstation, an advanced imaging, navigation, and mapping system for physicians to map, treat, re-map, and adjust additional therapy as needed; and Patient Electrode Kit that is required in every procedure to provide cardiac signals, catheter localization, and AcQMap system grounding. The company also provides diagnostic and monitoring devices, such as AcQMap 3D Imaging and Mapping Catheter that is used for mapping during the electrophysiology procedures; conventional diagnostic catheters, including multi-polar, steerable, and loop catheters that are used during the mapping and ablation procedures; and reprocessed diagnostic catheters, such as diagnostic, multipole, fixed, steerable, and advanced mapping and imaging catheters. In addition, the company provides access devices, which include AcQRef Introducer that provides stable electrical reference and vascular access; AcQGuide MAX Steerable Introducer, which provides a stable platform for catheter passage and precision placement; and Transseptal Access Products. Further, it offers therapeutic devices, such as AcQBlate FORCE Ablation Catheters, AlCath Ablation Catheters, MedFact Robotic Navigation Enabled Ablation Catheters, Qubic Force, Qubic RF Generator and Pulse Stimulator, and Qiona Pump. The company also provides various software mapping modes comprises single position, supermap, contact mapping, and stereotaxis integration. Acutus Medical, Inc. was founded in 2011 and is based in Carlsbad, California.